Introduction
At a time of increasing concern about illicit importation of heroin into the United Kingdom and about the apparently epidemic nature of use of heroin by young people in certain localities it seemed appropriate to review recent experience of opiate dependence in the United Kingdom. To study deaths of addicts may, at first sight, seem unhelpful-rather like shutting the door after the horse has bolted. Mortality studies, however, are recognised internationally as useful investigative tools for indicating trends in addiction to drugs. '-5 Taken in isolation the results may be of limited value, but taken in conjunction with those of other studies-for example, of prescribing trends or problems related to drugs in accident and emergency departments-they give a more complete picture of drug taking behaviour and drug dependence, and, by definition, mortality studies provide data about the most serious forms of drug addiction-that is, those from which the addict has died.
A useful source of information in the United Kingdom is the Home Office index of addicts. Before 1968 this was based on a system of voluntary notification by medical practitioners and of inspecting the books of dispensing chemists. Since the introduction in 1968 of the Dangerous Drugs (Notification of Addicts) Regulations, however, medical practitioners have had a statutory duty to notify the Home Office of any addict whom they attend; the current index of addicts is derived from these notifications. The Home Office also keeps a separate list of those addicts removed from the current index by reason of death, though there are no statutory obligations requiring that the Home Office should be informed of an addict's death; the information is derived from the returns made every two months by drug dependence treatment clinics to the Home Office and from information from coroners' courts, police, etc.
The usefulness, completeness, and representativeness of the Home Office statistics have been the subject of much discussion and some investigations.' 6 Though the statistics are incomplete and probably unrepresentative, they undoubtedly provide useful information about a large number of addicts, and this valuable source of data should not be ignored. We therefore examined, in some detail, the file of deaths of addicts during 1967-81. The starting date of 1967 was chosen because that was the year that the Dangerous Drugs Act was passed and the treatment of drug dependence in the United Kingdom changed direction.7 Drugs had been easily obtainable to therapeutic addicts but with a rise in non-therapeutic addiction, restrictions on prescription and on addicts developed.
Method
The Home Office index of addicts who had died was searched and the records of notified addicts who had died from 1967 to 1981 examined. Data were extracted in a standardised manner without revision. The search was carried out twice: once in 1979-80 and again in 1982. In the second search a few additional cases were identified, but none of these deaths had occurred more than four years previously. This implied that notification of death was sometimes delayed, and though the figures for 1980 and 1981 may have been incomplete, those for earlier years were reasonably accurate.
The information obtained was transferred to a specially designed, precoded inventory for statistical analysis. To preserve confidentiality names were not transferred.
Results

NUMBER OF DEATHS
The total number of deaths of addicts during the 15 year study was 1499, and clear differences between therapeutic and non-therapeutic addicts in terms of their age at death. Over half of the therapeutic addicts were aged 50 or more when they died compared with only 50o of the nontherapeutic addicts, two thirds of whom were aged under 30 (table II) . The cohort of addicts notified each year was also examined separately to establish the number of deaths at the end of successive calendar years and to calculate the mortalities among successive cohorts. Table III and figure 3 show that 1-9"O of addicts notified during 1967 were dead by 31 December of that year (within one year of notification), 3-50o by the end of 1968 (within two years), and so on. There was little difference between successive cohorts for the first two years of follow up. After 1973, however, there appeared to be a steady fall in the mortality among successive cohorts during the third, fourth, and fifth calendar years of follow up. The mean percentage mortality for each year of follow up was 1-6o" in the first year; 3-3°, in the second; Although the sex distribution of addicts who died again showed the longstanding preponderance of men among non-therapeutic addicts, there was clear evidence over the 15 years of a trend towards addicts dying at an older age. One possible interpretation 427 of this, of a static but aging population of addicts, is contradicted by the large number of new notifications each year. The mean age at notification also increased, however, particularly from 1973 to 1979, after which it remained more or less constant. Whether an older age at notification implies a longer period of drug abuse before notification or just a later start cannot be deduced from this study.
Perhaps the most important aspect of this inquiry was the opportunity to study so many annual cohorts of addicts, and the fairly constant early (first and second year) death rates for these cohorts over such a long period are of great interest. The 15 year study encompassed a range of different enthusiasms and policies for treating addiction: in the early years clinics opened and started prescribing heroin; then injectable methadone was substituted, and then oral methadone. Clinics have recently become more reluctant to prescribe opiates and may do so only as part of a therapeutic contract. None of these measures seems to have had any impact on early mortality, and the uniformity of the results over 15 years suggests that these death rates are perhaps the elusive "natural history" of addiction. In other words, just as x00 of patients with carcinoma of the stomach die within five years after notification so 1 6% of addicts die within one calendar year after notification, 3-3% within two years, and so on. Interestingly, this 3-3% is nearly identical with the comparable figure calculated by Bewley et al for a 1965 cohort before the clinics opened. 8 We should perhaps point out that the choice of calendar years for follow up periods was dictated by the system used at the Home Office for collecting and recording data. In fact, some addicts who were dead by the end of the calendar year in which they were notified may have been known to the Home Office for only a few weeks before death. The true death rate for the first year therefore approaches 300, for the second year 1 -9%, and for the third year 0 70/0.
The apparent reduction in mortality over the longer periods of follow up from 1974 onwards is encouraging. The cause cannot be ascertained from this study, but one factor may have been the reduced availability of barbiturates. By this time too the clinics, which in the early years had been feeling their way, were becoming more settled and new treatment and rehabilitation policies were more effective. Evidence suggests that the outpatient clinic system in the United Kingdom contributes to a higher incidence of abstinence than elsewhere. 9 Further evidence of the downward trend in mortality comes from the figures for crude mortality. Using data from a similar inquiry carried out by Bewley et Throughout the 15 year study there was anxiety and publicity about illicit heroin imported at different times from different places, such as the "golden triangle" of South East Asia, postrevolutionary Iran, and, latterly, north west Pakistan. Interestingly, heroin had a role in only 7 00 of the deaths in which a drug was implicated, and some of this heroin may have been medically prescribed rather than illicitly imported. In contrast, most deaths of addicts in which a drug was implicated were due to medically prescribed drugs: barbiturates in the earlier years of the study and more recently "other opiates," mostly dipipanone hydrochloride and dextromoramide. This in no way minimises the problem presented by illicitly imported drugs. Their easy availability may provide the stepping stone into drug abuse and addiction for a large number of young people, and it is essential that as far as possible these drugs should be kept out of the country.
These findings are not confined to the deaths of notified addicts as they are similar to the results of studies carried out in coroners' courts into deaths due to addiction. In one such study 41 % of the deaths were of addicts not known to the Home Office. ' By definition, mortality studies deal with the most serious forms of addiction, from which the patient dies. What is apparent from our findings is that prescribed drugs rather than illicitly imported drugs are at the core of this aspect of the problem. Far from being a new phenomenon, prescribed drugs have always played a large part in addiction in Britain, and this may be the inevitable consequence of a medical, rather than a criminalising, response to addiction. Whatever the underlying reasons, the fact that prescribed drugs are causing so many deaths of addicts demands a response from the medical profession from whom these drugs originate. An active system of monitoring is the first requirement to identify new drugs of abuse before they have become entrenched in the black market.
This study has shown the value of one particular source of information, the Home Office index, in investigating and identifying serious problems of addiction. The epidemiological characteristics of platelet aggregability were established in 958 participants in the Northwick Park Heart Study. The main analyses were based on the dose of adenosine diphosphate at which primary aggregation occurred at half its maximum velocity. Aggregability increased with age in both sexes, was greater in whites than blacks (particularly among men), and tended to decrease with the level of habitual alcohol consumption. Aggregability was, however, greater in women than men and in nonsmokers than smokers. There was no relation between aggregability on the one hand and obesity, current or past oral contraceptive use, menopausal state, or blood cholesterol and triglyceride concentrations on the other. Aggregability was somewhat, though not significantly, higher in men with a history of ischaemic heart disease and in those with electrocardiographic evidence of ischaemia than in those without. There was a strong association between the plasma fibrinogen concentration and aggregability.
Introduction
The role of platelets in thrombosis has been the subject of numerous studies for many years, especially over the past two decades. There is, however, no established measure of in vivo platelet function by which those at high risk of thrombosis can be characterised. In 1962 Born described a method for studying platelet aggregation that was based on changes in the optical density of a suspension of platelets.' 2 This method, or modifications of it, has since been widely used in laboratory and clinical studies on the assumption that ready aggregability is an index of susceptibility to thrombosis. Here we describe the epidemiological characteristics of platelet aggregability seen in the Northwick Park Heart Study, a prospective study of the role of the haemostatic system in the pathogenesis of arterial disease.
Subjects and methods
SUBJECTS
Fuller details of the Northwick Park Heart Study have been published elsewhere.3 In summary, 3500 participants were recruited
